Vaxart Inc (VXRT)
0.70
-0.01
(-2.06%)
USD |
NASDAQ |
May 01, 16:00
0.7017
0.00 (0.00%)
Pre-Market: 08:40
Vaxart Cash from Operations (TTM): -70.45M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -70.45M |
September 30, 2023 | -86.08M |
June 30, 2023 | -85.70M |
March 31, 2023 | -94.13M |
December 31, 2022 | -94.78M |
September 30, 2022 | -81.44M |
June 30, 2022 | -81.09M |
March 31, 2022 | -68.35M |
December 31, 2021 | -59.83M |
September 30, 2021 | -54.78M |
June 30, 2021 | -49.77M |
March 31, 2021 | -37.13M |
December 31, 2020 | -23.75M |
September 30, 2020 | -16.78M |
June 30, 2020 | -11.85M |
March 31, 2020 | -11.64M |
December 31, 2019 | -13.09M |
September 30, 2019 | -15.00M |
June 30, 2019 | -16.03M |
March 31, 2019 | -8.611M |
December 31, 2018 | -14.55M |
September 30, 2018 | -13.55M |
June 30, 2018 | -12.69M |
March 31, 2018 | -18.59M |
December 31, 2017 | -19.50M |
Date | Value |
---|---|
September 30, 2017 | -23.80M |
June 30, 2017 | -30.00M |
March 31, 2017 | -30.10M |
December 31, 2016 | -25.60M |
September 30, 2016 | -25.70M |
June 30, 2016 | -14.10M |
March 31, 2016 | -15.00M |
December 31, 2015 | -7.20M |
September 30, 2015 | 2.90M |
June 30, 2015 | -9.60M |
March 31, 2015 | 0.80M |
December 31, 2014 | 0.70M |
September 30, 2014 | -8.70M |
June 30, 2014 | -3.30M |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | -6.293M |
June 30, 2012 | -9.875M |
March 31, 2012 | -8.078M |
December 31, 2011 | -15.17M |
September 30, 2011 | -16.01M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-94.78M
Minimum
Dec 2022
-11.64M
Maximum
Mar 2020
-51.14M
Average
-54.78M
Median
Sep 2021
Cash from Operations (TTM) Benchmarks
Novavax Inc | -713.97M |
aTyr Pharma Inc | -33.22M |
Allogene Therapeutics Inc | -237.73M |
AIM ImmunoTech Inc | -21.27M |
Protalix BioTherapeutics Inc | -1.318M |